Guangdong Taienkang Pharmaceutical Co., Ltd. (SHE:301263)

Revenue by Product

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Pharmaceutical Agent	440.52M
Pharmaceutical Agent Growth	2.38%
Pharmaceutical Manufacturing	268.79M
Pharmaceutical Manufacturing Growth	-17.30%
Medical Technology Services	10.87M
Medical Technology Services Growth	128.22%
Other	862.97K
Other Growth	20.49%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
China	720.77M
China Growth	-5.26%
Foreign	264.15K
Foreign Growth	1100.69%